COVID-19 Vaccine Likely by Early 2021

The COVID-19 vaccine would most likely be ready by the first quarter of 2021. The government is planning first to vaccinate senior citizens and high-risk people.

Coronavirus vaccine is likely to be ready by the first quarter of 2021, according to Union Health and Family Welfare Minister.

The government is considering emergency authorization of the COVID-19 vaccine to senior citizens and people at high risk of contracting the virus. This will be done after a consensus has been reached.

How to Deal With Dengue During the COVID-19 Pandemic?
The overlapping symptoms of dengue and COVID-19 infection makes it difficult to distinguish between the two. Besides, a lack of a vaccine or specific antiviral treatment for both diseases makes dengue a double whammy during the COVID-19 pandemic.

‘COVID-19 vaccine is likely to be ready by early 2021. High-risk people and senior citizens would first be vaccinated.’
Read More..

The National Expert Group on Vaccine Administration for COVID-19 is strategizing on how to immunize the majority of the population.

The government is also taking full precautions in conducting the human trials for the COVID-19 vaccine, according to the Minister.

“Issues like vaccine security, cost, equity, cold-chain requirements, production timelines are also being discussed intensely,” he said.

Role of Unconventional T Cells in Severe COVID-19 Patients
Changes in unconventional T cells can predict the disease outcome in severe COVID-19 patients. These changes can be observed by monitoring the activity of these cells in the blood of patients.

The Minister assured that the COVID-19 vaccine would be first made available to the people who need it the most, irrespective of their paying capacity.

He would also be happy to take the first dosage of the COVID-19 vaccine in case some people have a trust deficit.

Coronavirus Facts from Autopsy Reports of COVID-19 Patients
Autopsies onCOVID-19 patients reveals a lot of information on the virus. There have been no reports of COVID-19 transmission between a corpse and a pathologist.

The Minister gave his statement after one of the participants in the ongoing clinical trial of the University of Oxford’s COVID-19 vaccine candidate developed a severe complication right after being administered the dose.

The Minister also informed about vaccine candidates and their development in India.

How Has COVID-19 Impacted Use of Telehealth Visits?
Older adults are increasingly comfortable with telehealth, especially in 2020, due to the COVID-19 pandemic. Telehealth is an effective means for older adults to access health care from the safety of their own homes.

Department of Biotechnology (DBT) along with the Indian Council of Medical Research (ICMR), has been actively supporting the advancement of vaccine candidates.

India is also partnering with the Coalition for Epidemic Preparedness Innovations (CEPI). The trials at different phases are ongoing concerning several vaccines in private or public Indian laboratories and hospitals.

The minister also noted that an effective and safe vaccine would help in establishing immunity to COVID-19 at a much faster pace as compared to natural infection.

He hopes that a consensus will emerge in the next few months over the desired level of protective herd immunity in any community.

Source-Medindia